Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ajanta Pharma Ltd (AJPH)
Ajanta Pharma Ltd stock price live, this page displays NSE AJPH stock exchange data. View the AJPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ajanta Pharma Ltd real time stock price chart below.
What Is the Ajanta Pharma Ltd Stock Price Today?
The Ajanta Pharma Ltd stock price today is 3,307.70.
What Is the Stock Symbol for Ajanta Pharma Ltd?
The stock symbol for Ajanta Pharma Ltd is "AJPH."
What Stock Exchange Does Ajanta Pharma Ltd Trade On?
Ajanta Pharma Ltd is listed and trades on the NSE stock exchange.
Is Ajanta Pharma Ltd a Good Stock to Buy?
Determining whether Ajanta Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AJPH quote. (ISIN: INE031B01049)
What Is the Ajanta Pharma Ltd Stock Price Today?
The Ajanta Pharma Ltd stock price today is 3,307.70.
What Is the Stock Symbol for Ajanta Pharma Ltd?
The stock symbol for Ajanta Pharma Ltd is "AJPH."
What Stock Exchange Does Ajanta Pharma Ltd Trade On?
Ajanta Pharma Ltd is listed and trades on the NSE stock exchange.
Is Ajanta Pharma Ltd a Good Stock to Buy?
Determining whether Ajanta Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AJPH quote. (ISIN: INE031B01049)
3,307.70
+25.60(+0.78%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,252.10
3,339.50
52 wk Range
2,445.80
3,796.00
AJANTPHARM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,252.103,339.50
52 wk Range
2,445.803,796.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AJANTPHARM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3,865.77
Upside
+16.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Ajanta Pharma Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell
Analyst Ratings
9 Buy
3 Hold
2 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3,865.77
(+16.87% Upside)
Ajanta Pharma Ltd Earnings Call Summary for Q2/2027
- Ajanta Pharma Q2 FY2027 EPS hit 31.03 vs 25.13 est., revenue 17.94B rupees vs 16.02B est.; shares rose 1.42% to $3,508.8 in pre-market.
- Revenue jumped 33% YoY, PAT up 49%; EBITDA margin expanded to 30% from 27%, driven by strength across India, Asia, Africa and U.S. markets.
- Full-year guidance unchanged: high-teens revenue growth, ~27% EBITDA margin; H2 margins expected lower due to rising U.S. competition, higher R&D.
- U.S. generics growth to slow as new competitors enter; Africa institutional sales may normalize; semaglutide in-licensing to contribute from FY2028.
- Management emphasized three-year growth horizon with diversified geographic model; return on capital employed rose to 41% from 33% in March 2026.
Last Updated: 2026-11-01, 05:36 a/m
Read Full TranscriptEarnings
Latest Release
Oct 29, 2026
EPS / Forecast
31.03 / 25.13
Revenue / Forecast
17.94B / 16.02B
Compare AJANTPHARM to Peers and Sector
Metrics to compare | AJANTPHARM | Peers Peers - average of corresponding metrics from companies closely matching AJANTPHARM: MANKIND, GLENMARK, CIPLA, CAPLIPOINT, EMCURE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAJANTPHARMPeersSector |
|---|---|---|---|---|
P/E Ratio | 32.7x | 32.8x | −0.2x | |
PEG Ratio | 1.10 | 0.99 | 0.00 | |
Price/Book | 8.5x | 5.0x | 2.6x | |
Price / LTM Sales | 6.6x | 5.7x | 2.8x | |
Upside (Analyst Target) | 16.9% | 14.4% | 65.6% | |
Fair Value Upside | Unlock | −1.1% | 10.0% | Unlock |
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ajanta Pharma Ltd (AJANTPHARM) Stock Price Today?
The Ajanta Pharma Ltd stock price today is 3,307.70 INR.
What Stock Exchange Does Ajanta Pharma Ltd Trade On?
Ajanta Pharma Ltd is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Ajanta Pharma Ltd?
The stock symbol for Ajanta Pharma Ltd is "AJANTPHARM."
Does Ajanta Pharma Ltd Pay Dividends? What’s The Current Dividend Yield?
The Ajanta Pharma Ltd dividend yield is 1.8%%.
What Is the Ajanta Pharma Ltd Market Cap?
As of today, Ajanta Pharma Ltd market cap is 413.25B INR.
What Is Ajanta Pharma Ltd's Earnings Per Share (TTM)?
The Ajanta Pharma Ltd EPS (TTM) is 101.07.
When Is the Next Ajanta Pharma Ltd Earnings Date?
Ajanta Pharma Ltd will release its next earnings report on Feb 03, 2027.
From a Technical Analysis Perspective, Is AJANTPHARM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ajanta Pharma Ltd Stock Split?
Ajanta Pharma Ltd has split 4 times.
How Many Employees Does Ajanta Pharma Ltd Have?
Ajanta Pharma Ltd has 10421 employees.
What is the current trading status of Ajanta Pharma Ltd (AJANTPHARM)?
As of Nov 07, 2026, Ajanta Pharma Ltd (AJANTPHARM) is trading at a price of 3,307.70 INR, with a previous close of 3,282.10 INR. The stock has fluctuated within a day range of 3,252.10 INR to 3,339.50 INR, while its 52-week range spans from 2,445.80 INR to 3,796.00 INR.
What Is Ajanta Pharma Ltd (AJANTPHARM) Price Target According to Analysts?
The average 12-month price target for Ajanta Pharma Ltd is 3,865.77 INR, with a high estimate of 4330 INR and a low estimate of 3109 INR. 9 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +16.87% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.